Isolation of Extended-Spectrum β-lactamase- (ESBL-) Producing Escherichia coli and Klebsiella pneumoniae from Patients with Community-Onset Urinary Tract Infections in Jimma University Specialized Hospital, Southwest Ethiopia

Table 5

Frequency of multidrug resistance pattern of ESBL-producing isolates from community-onset UTI patients in JUSH, Southwest of Ethiopia.

Antibiotic classes	MDR rate (N (%))
Beta-lactams + SXT, T	14 (82.4%)
Beta-lactams + SXT, T, NA	13 (76.5%)
Beta-lactams + SXT, T, NA, CIP, GEN	11 (64.7%)
Beta-lactams + SXT, T, NA, CIP, GEN, C	9 (52.9%)
Beta-lactams + SXT, T, NA, CIP, GEN, AK, C	4 (23.5%)

Beta-lactams: (ampicillin, cephalothin, amoxicillin-clavulanic acid, cefotaxime, ceftazidime, and ceftriaxone), GEN: gentamicin, AK: amikacin, CIP: ciprofloxacin, SXT: trimethoprim-sulfamethoxazole, T: tetracycline, NA: nalidixic acid, C: chloramphenicol.